BUZZ-U.S. STOCKS ON THE MOVE-NPS Pharma, Foundation Medicine, Biogen
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index e-mini futures rose on Monday: Dow Jones industrial average futures were up 0.52 percent at 17,741, S&P 500 futures were up 0.55 percent at 2,046.5 and Nasdaq 100 futures were up 0.54 percent at 4,223.5.
** NPS PHARMACEUTICALS INC, Friday close $41.91, +8.76 pct premarket
British drugmaker Shire Plc has agreed to buy U.S. group NPS Pharmaceuticals for $5.2 billion, its biggest acquisition yet as it seeks to strengthen its position in the lucrative field of medicines for rare diseases. Shire will pay $46 per NPS share, representing a premium of nearly 10 percent to NPS's Friday close, the two companies said on Sunday.
** BRISTOL-MYERS SQUIBB CO, Friday close $60.32, +5.69 pct premarket
The pharmaceutical company said the independent data monitoring committee concluded that a late-stage study evaluating Opdivo versus docetaxel in previously treated patients with advanced, squamous cell non-small cell lung cancer met its endpoint.
** FOUNDATION MEDICINE INC, Friday close $23.93, +107.90 pct premarket Continued...